Skip to main content
1.888.799.9666
JOIN A MEETING
HOST A MEETING
With Video Off
With Video On
HOST A MEETING WITH VIDEO
HOST A MEETING WITHOUT VIDEO
1.888.799.9666
SALES
PLANS
SIGN IN
SIGN UP, IT'S FREE
SIGN UP, IT'S FREE
webinar register page
NeoGenomics Lung Cancer Tumor Board Registration
Facebook
Twitter
LinkedIn
Microsoft (Outlook)
Topic
NeoGenomics Lung Cancer Tumor Board
Description
NeoGenomics is proud to offer our Molecular Tumor Boards covering relevant topics in cancer care.
Each session, multidisciplinary teams will submit and discuss 2 - 4 patients with expert oncologists. For more information on this and our other tumor boards, please visit https://neogenomics.com/client-services/education/tumor-boards (copy and paste into browser).
Upcoming dates:
March 11
April 7
May 5
June 2
We look forward to having you join us. Please contact the Scientific Collaboration & Engagement team at tumorboards@neogenomics.com to inquire about submitting cases for review, or for any questions.
Time
Mar 11, 2021 11:00 AM
Apr 7, 2021 11:00 AM
May 5, 2021 11:00 AM
Jun 2, 2021 11:00 AM
Time shows in
Central Time (US and Canada)
*
Required information
Loading
By registering, I agree to the
Privacy Statement
and
Terms of Service
.
Register
Speakers
Narjust Duma, MD
Assistant Professor of Medicine in the Division of Hematology, Medical Oncology, and Palliative Care @UWHealth
Dr. Narjust Duma is a faculty member in the Division of Hematology, Medical Oncology and Palliative Care. She is a medical oncologist with clinical and research focus on thoracic malignancies. She has been recognized for her work with numerous awards, including the Mayo Brothers Distinguished Fellowship Award, considered the highest trainee honor in the Mayo Clinic School of Graduate Medical Education; the Merit Award/ASCO Employees Endowed Merit Award, American Society of Clinical Oncology; and the Next-Generation Innovators Award, HemOnc Today - Healio, Scholar in Training Award, 11th American Association of Cancer Research (AACR) conference on the science of cancer health disparities in racial/ethnic minorities and the medically underserved. Dr. Duma's clinical interests include medical oncology with emphasis on thoracic cancer, including small cell and non-small cell lung cancer, thymic malignancies and mesothelioma.
Hutan Husain, MD
Associate Professor of Medicine @UC San Diego Health
Dr Husain is a board-certified medical oncologist who specializes in treating lung cancer and brain tumors. In addition to instructing medical students, residents and fellows, he is also a physician-scientist dedicated to understanding the cancer genome and how to advance meaningful, precision-oriented therapies for patients. Dr. Husain has developed a translational research focus and collaborates with scientists to bring discoveries from bench-to-bedside. His efforts include expanding tools for tracking cancer growth specifically through circulating tumor DNA analyses; understanding the mechanisms of cancer formation in non-smoking patients; and investigating how the genome can provide clues to optimal treatments and new therapies. He completed a fellowship in medical oncology at Johns Hopkins School of Medicine and a residency in internal medicine at Keck School of Medicine of USC. Dr. Husain earned his medical degree from Northwestern University Feinberg School of Medicine.
×
Share via Email
All fields are required
Your Information
Send to
Message preview
Hi there, You are invited to a Zoom webinar. When: Mar 11, 2021 11:00 AM Central Time (US and Canada) Topic: NeoGenomics Lung Cancer Tumor Board Register in advance for this webinar: https://neogenomics.zoom.us/webinar/register/WN_tNDeZBjgSMeTKsfia0Yd0A Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) 162.255.36.11 (US East) 115.114.131.7 (India Mumbai) 115.114.115.7 (India Hyderabad) 213.19.144.110 (Amsterdam Netherlands) 213.244.140.110 (Germany) 103.122.166.55 (Australia Sydney) 103.122.167.55 (Australia Melbourne) 149.137.40.110 (Singapore) 64.211.144.160 (Brazil) 69.174.57.160 (Canada Toronto) 65.39.152.160 (Canada Vancouver) 207.226.132.110 (Japan Tokyo) 149.137.24.110 (Japan Osaka) Meeting ID: 978 1187 6893 SIP: 97811876893@zoomcrc.com After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Narjust Duma, MD (Assistant Professor of Medicine in the Division of Hematology, Medical Oncology, and Palliative Care @UWHealth ) Dr. Narjust Duma is a faculty member in the Division of Hematology, Medical Oncology and Palliative Care. She is a medical oncologist with clinical and research focus on thoracic malignancies. She has been recognized for her work with numerous awards, including the Mayo Brothers Distinguished Fellowship Award, considered the highest trainee honor in the Mayo Clinic School of Graduate Medical Education; the Merit Award/ASCO Employees Endowed Merit Award, American Society of Clinical Oncology; and the Next-Generation Innovators Award, HemOnc Today - Healio, Scholar in Training Award, 11th American Association of Cancer Research (AACR) conference on the science of cancer health disparities in racial/ethnic minorities and the medically underserved. Dr. Duma's clinical interests include medical oncology with emphasis on thoracic cancer, including small cell and non-small cell lung cancer, thymic malignancies and mesothelioma. Hutan Husain, MD (Associate Professor of Medicine @UC San Diego Health ) Dr Husain is a board-certified medical oncologist who specializes in treating lung cancer and brain tumors. In addition to instructing medical students, residents and fellows, he is also a physician-scientist dedicated to understanding the cancer genome and how to advance meaningful, precision-oriented therapies for patients. Dr. Husain has developed a translational research focus and collaborates with scientists to bring discoveries from bench-to-bedside. His efforts include expanding tools for tracking cancer growth specifically through circulating tumor DNA analyses; understanding the mechanisms of cancer formation in non-smoking patients; and investigating how the genome can provide clues to optimal treatments and new therapies. He completed a fellowship in medical oncology at Johns Hopkins School of Medicine and a residency in internal medicine at Keck School of Medicine of USC. Dr. Husain earned his medical degree from Northwestern University Feinberg School of Medicine.
×
Switch Time Zone
Time Zone:
(GMT-11:00) Midway Island, Samoa
(GMT-11:00) Pago Pago
(GMT-10:00) Hawaii
(GMT-9:00) Alaska
(GMT-9:00) Juneau
(GMT-8:00) Vancouver
(GMT-8:00) Pacific Time (US and Canada)
(GMT-8:00) Tijuana
(GMT-7:00) Edmonton
(GMT-7:00) Mountain Time (US and Canada)
(GMT-7:00) Arizona
(GMT-7:00) Mazatlan
(GMT-7:00) Chihuahua
(GMT-6:00) Winnipeg
(GMT-6:00) Saskatchewan
(GMT-6:00) Central Time (US and Canada)
(GMT-6:00) Mexico City
(GMT-6:00) Guatemala
(GMT-6:00) El Salvador
(GMT-6:00) Managua
(GMT-6:00) Costa Rica
(GMT-6:00) Tegucigalpa
(GMT-6:00) Monterrey
(GMT-5:00) Montreal
(GMT-5:00) Eastern Time (US and Canada)
(GMT-5:00) Indiana (East)
(GMT-5:00) Panama
(GMT-5:00) Bogota
(GMT-5:00) Lima
(GMT-4:00) Halifax
(GMT-4:00) Puerto Rico
(GMT-4:00) Caracas
(GMT-4:00) Atlantic Time (Canada)
(GMT-4:00) La Paz
(GMT-4:00) Guyana
(GMT-3:30) Newfoundland and Labrador
(GMT-3:00) Santiago
(GMT-3:00) Montevideo
(GMT-3:00) Recife
(GMT-3:00) Buenos Aires, Georgetown
(GMT-3:00) Greenland
(GMT-3:00) Sao Paulo
(GMT-1:00) Azores
(GMT-1:00) Cape Verde Islands
(GMT+0:00) Universal Time UTC
(GMT+0:00) Greenwich Mean Time
(GMT+0:00) Reykjavik
(GMT+0:00) Dublin
(GMT+0:00) London
(GMT+0:00) Lisbon
(GMT+0:00) Nouakchott
(GMT+1:00) Belgrade, Bratislava, Ljubljana
(GMT+1:00) Sarajevo, Skopje, Zagreb
(GMT+1:00) Casablanca
(GMT+1:00) Oslo
(GMT+1:00) Copenhagen
(GMT+1:00) Brussels
(GMT+1:00) Amsterdam, Berlin, Rome, Stockholm, Vienna
(GMT+1:00) Amsterdam
(GMT+1:00) Rome
(GMT+1:00) Stockholm
(GMT+1:00) Vienna
(GMT+1:00) Luxembourg
(GMT+1:00) Paris
(GMT+1:00) Zurich
(GMT+1:00) Madrid
(GMT+1:00) West Central Africa
(GMT+1:00) Algiers
(GMT+1:00) Tunis
(GMT+1:00) Warsaw
(GMT+1:00) Prague Bratislava
(GMT+1:00) Budapest
(GMT+2:00) Helsinki
(GMT+2:00) Harare, Pretoria
(GMT+2:00) Sofia
(GMT+2:00) Athens
(GMT+2:00) Bucharest
(GMT+2:00) Nicosia
(GMT+2:00) Beirut
(GMT+2:00) Damascus
(GMT+2:00) Jerusalem
(GMT+2:00) Amman
(GMT+2:00) Tripoli
(GMT+2:00) Cairo
(GMT+2:00) Johannesburg
(GMT+2:00) Khartoum
(GMT+2:00) Kiev
(GMT+3:00) Nairobi
(GMT+3:00) Istanbul
(GMT+3:00) Moscow
(GMT+3:00) Baghdad
(GMT+3:00) Kuwait
(GMT+3:00) Riyadh
(GMT+3:00) Bahrain
(GMT+3:00) Qatar
(GMT+3:00) Aden
(GMT+3:00) Djibouti
(GMT+3:00) Mogadishu
(GMT+3:00) Minsk
(GMT+3:30) Tehran
(GMT+4:00) Dubai
(GMT+4:00) Muscat
(GMT+4:00) Baku, Tbilisi, Yerevan
(GMT+4:30) Kabul
(GMT+5:00) Yekaterinburg
(GMT+5:00) Islamabad, Karachi, Tashkent
(GMT+5:30) India
(GMT+5:30) Mumbai, Kolkata, New Delhi
(GMT+5:45) Kathmandu
(GMT+6:00) Almaty
(GMT+6:00) Dacca
(GMT+6:00) Astana, Dhaka
(GMT+6:30) Rangoon
(GMT+7:00) Novosibirsk
(GMT+7:00) Krasnoyarsk
(GMT+7:00) Bangkok
(GMT+7:00) Vietnam
(GMT+7:00) Jakarta
(GMT+8:00) Irkutsk, Ulaanbaatar
(GMT+8:00) Beijing, Shanghai
(GMT+8:00) Hong Kong SAR
(GMT+8:00) Taipei
(GMT+8:00) Kuala Lumpur
(GMT+8:00) Singapore
(GMT+8:00) Perth
(GMT+9:00) Yakutsk
(GMT+9:00) Seoul
(GMT+9:00) Osaka, Sapporo, Tokyo
(GMT+9:30) Darwin
(GMT+10:00) Vladivostok
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Brisbane
(GMT+10:30) Adelaide
(GMT+11:00) Canberra, Melbourne, Sydney
(GMT+11:00) Hobart
(GMT+11:00) Magadan
(GMT+11:00) Solomon Islands
(GMT+11:00) New Caledonia
(GMT+12:00) Kamchatka
(GMT+12:00) Fiji Islands, Marshall Islands
(GMT+13:00) Auckland, Wellington
(GMT+14:00) Independent State of Samoa
×
Continue to PayPal
Click to Continue
×
×
Upcoming Meetings
Would you like to start this meeting?
Would you like to start one of these meetings?
View more...